Press "Enter" to skip to content

Ra Medical Systems, the Maker of DABRA Excimer Laser that Produces UVB Photons to Minimize Chemical Compounds in the Body, Submits its Prospectus to SEC

Ra Medical Systems, Inc. delivered its Form 424B1 Prospectus to the U.S. Securities and Exchange Commission on February 7, 2022.The prospectus relates to the offering of 9,535,000 units of Ra Medical Systems, Inc., consisting of one (1) share of common stock, one (1) warrant to purchase one share of their common stock at an exercise…

This content is viewable by members only. Visit MY ACCOUNT on the top menu to log in or to register for a 30 day free trial or purchase a subscription for UV Reporter 1 Year Single Membership or UV Reporter 1 Year Group Membership - $189 for first member and $25 for each additional member.